表紙
市場調查報告書
商品編碼
1057498

植入式藥物輸送設備的全球市場(2021年∼2028年)

Global Implantable Drug Delivery Devices Market - 2021-2028

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球植入式藥物輸送設備市場相關調查分析,提供市場動態,產業分析,市場分析,競爭情形等系統性資訊。

目錄

第1章 全球植入式藥物輸送設備市場-調查手法和範圍

  • 調查手法
  • 調查的目的和調查範圍

第2章 全球植入式藥物輸送設備市場-市場定義和概要

第3章 全球植入式藥物輸送設備市場-摘要整理

  • 市場明細:各產品類型
  • 市場明細:各技術
  • 市場明細:各應用領域
  • 市場明細:各終端用戶
  • 市場明細:各地區

第4章 全球植入式藥物輸送設備市場-市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球植入式藥物輸送設備市場-產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 全球植入式藥物輸送設備市場-COVID-19分析

  • 市場上的COVID-19分析
    • COVID-19前的市場方案
    • 目前COVID-19市場方案
    • COVID-19後的市場方案/未來市場方案
  • COVID-19的價格動態
  • 需求與供給的頻譜
  • 政府在COVID-19疫情下的市場相關措施
  • 製造商策略性舉措
  • 結論

第7章 全球植入式藥物輸送設備市場-產品類型

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析(%):各產品類型
    • 市場魅力指數:各產品類型
  • 避孕用植入*
    • 簡介
    • 市場規模分析(100萬美元)(2019年∼2028年),及與前一年同期比較成長分析(%)(2020年∼2028年)
  • 脊椎移植
  • 輸液幫浦
  • 眼內支架
  • 生物可吸收支架
  • 藥物釋放型性支架
  • 近接治療種子
  • 其他

第8章 全球植入式藥物輸送設備市場:各技術

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析(%):各技術
    • 市場魅力指數:各技術
  • 生物分解性藥物輸送技術*
    • 簡介
    • 市場規模分析(100萬美元)(2019年∼2028年),及與前一年同期比較成長分析(%)(2020年∼2028年)
  • 非生物分解性藥物輸送技術

第9章 全球植入式藥物輸送設備市場:各應用領域

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析(%):各應用領域
    • 市場魅力指數:各應用領域
  • 避孕*
    • 簡介
    • 市場規模分析(100萬美元)(2019年∼2028年),及與前一年同期比較成長分析(%)(2020年∼2028年)
  • 心血管
  • 眼科
  • 糖尿病
  • 腫瘤學
  • 自體免疫疾病
  • 其他

第10章 全球植入式藥物輸送設備市場:各終端用戶

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析(%):各終端用戶
    • 市場魅力指數:各終端用戶
  • 醫院*
    • 簡介
    • 市場規模分析(100萬美元)(2019年∼2028年),及與前一年同期比較成長分析(%)(2020年∼2028年)
  • 門診病人手術中心
  • 其他

第11章 全球植入式藥物輸送設備市場:各地區

  • 簡介
    • 市場規模分析(100萬美元)(2019年∼2028年),及與前一年同期比較成長分析(%)(2020年∼2028年):各地區
    • 市場魅力指數:各地區
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東和非洲

第12章 全球植入式藥物輸送設備市場-競爭情形

  • 主要的發展與策略
  • 企業佔有率分析
  • 產品的基準
  • 值得注意的主要企業的清單

第13章 全球植入式藥物輸送設備市場-企業簡介概要

  • Abbott Laboratories*
    • 企業概要
    • 產品系列及說明
    • 主要亮點
    • 財務概要
  • AbbVie Inc.
  • Delpor Inc.
  • Medtronic
  • Bausch & Lomb
  • Cognos Therapeutics, Inc.
  • Bayer
  • Zimmer Biomet
  • Elixir Medical Corporation
  • DSM Biomedical

第14章 全球植入式藥物輸送設備市場-DataM

  • 附錄
  • 關於本公司
  • 諮詢方式
目錄
Product Code: DMMD4605

Market Overview

Implantable drug delivery systems (IDDSs) are bioengineering devices surgically implanted inside the patient's tissues to escape first-pass metabolism and lessen systemic toxicity of the medicine by eluting the therapeutic payload near the target tissues.

The global implantable drug delivery devices market size was valued US$ XX million in 2020 and is estimated to reach US$ XX million by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Market Dynamics

A novel treatment system for neurological medical emergencies is expected to drive market growth.

Personalized biomedical devices have a lot of potentials when it comes to solving clinical problems in emergency scenarios. Despite this potential, a device for treating fatal seizures in the field with pharmaceutical approaches has yet to be created. Using a soft implantable drug delivery device(SID) for a novel treatment method for neurological medical crises such as status epilepticus, a lethal epileptic condition that requires prompt treatment (SID). Wireless voltage induction allows the SID to communicate with wearable devices to monitor electroencephalography signals and trigger subcutaneous medication release. Bulky stiff components like sensors, batteries, and electrical circuits can be shifted from the SID to wearables thanks to wireless integration, allowing the SID to attain mechanical softness and downsizing. Thus, brain damages are reduced, and survival rates are increased due to which the market is expected to drive in the forecast period.

Restraint:

Device and surgery expenses are high, and adoption is minimal. For instance, SynchroMed II and SynchroMed EL are implantable medication infusion pumps created by Medtronic. Patients with metastatic cancer and chronic pain benefit from these pumps. The device had a software issue, prompting Medtronic to recall and update the product's firmware under FDA guidelines. Thus, these are some of the factors that the market is expected to hamper in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. COVID-19 affects the cardiovascular system, resulting in myocardial injury, intravascular thrombosis, arrhythmias, and sudden cardiac death. Reports have suggested a temporal association between COVID-19 activity and cardiac arrests in the community and in-hospital settings. Although a higher burden of ventricular arrhythmic events has been observed among hospitalized patients with COVID-19, the mechanisms underlying the surge of out-of-hospital cardiac arrests remain unclear. Individuals with an implantable cardioverter-defibrillator (ICD) are at increased risk for arrhythmic sudden cardiac arrest. Given the ability of these devices in providing continuous cardiac monitoring and therapy.

Additionally, the pandemic is interrupting the supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.

Segment Analysis

Biodegradable Drug Delivery Technology segment is expected to hold the largest market share in implantable drug delivery devices market.

The biodegradable drug delivery technology segment accounted for the largest market share in 2020. The advantages of biodegradable drug delivery technology include easy manufacture, absorption, and excretion of inter-polymers utilized in biodegradable devices, eliminating the need for surgical removal, which is required with non-biodegradable items. Additional benefits include increased acceptance, patient compliance, and better outcomes, which are expected to drive demand even higher. For instance, Ocular implants are increasingly made of biodegradable materials. These methods make it easier to administer medications with a long half-life and a high systemic dose, increasing the amount of drug that reaches the ocular tissues. Biodegradable implants include Lacrisert, Surodex, and Ozurdex, to name a few. Biodegradable polymers are also employed as medication carriers to help with localized and long-term drug delivery. Thus, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global implantable drug delivery devices market

In 2020, North America accounted for the highest revenue share. The increasing prevalence of chronic conditions, rising geriatric population, many technological and medical developments that have expanded the sorts of implantable devices are factors the market is expected to boost in the forecast period. Moreover, millions of people in the United States have implantable devices in their bodies, such as artificial hips or cardiac pacemakers. For instance, experts estimate that 7.2 million people in the United States have joint implants. Additionally, Pacemakers have become more accurate and effective due to technological breakthroughs. The following are some of the most recent developments, including Wireless pacemaker models that allow for greater connectivity and monitoring, Comprehensive data produced by the pacemaker that can be analyzed and used for monitoring the patient's condition and early intervention if a problem is detected, pacemakers that let the heart function on its own and intervene only when it is necessary to normalize a slow or irregular heart rhythm and improved battery life in pacemakers are some of the factors due to which the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the implantable drug delivery devices market are: Abbott Laboratories, AbbVie Inc., Delpor Inc., Medtronic, Bausch & Lomb, Cognos Therapeutics, Inc., Bayer, Zimmer Biomet , Elixir Medical Corporation and DSM Biomedical.

Medtronic plc:

Overview:

Medtronic plc is an American-Irish registered medical device company primarily operating in the United States. It has an operational and executive headquarters in Fridley, Minnesota, in the US. Moreover, it develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders and diabetes. It is operated in 140 countries and employs over 104,950 people.

Product Portfolio:

SYNCHROMED II INTRATHECAL PUMP: SynchroMed II Intrathecal Pump Intrathecal Drug Infusion System for Chronic Pain Management. The SynchroMed II programmable, implantable pump delivers the drug to the intrathecal space via an implanted catheter.

Why Purchase the Report?

  • Visualize the composition of the global implantable drug delivery devices market segmentation by product type, technology, application, end user and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in global implantable drug delivery devices market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global implantable drug delivery devices market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global implantable drug delivery devices market report would provide an access to an approx. 45+ market data table, 40+ figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Implantable Drug Delivery Devices Market - By Product Type

  • Contraceptive Implants
  • Spinal Implants
  • Infusion Pumps
  • Intraocular Stents
  • Bio-absorbable Stents
  • Drug-Eluting Stents
  • Brachytherapy Seeds
  • Others

Global Implantable Drug Delivery Devices Market - By Technology

  • Biodegradable Drug Delivery Technology
  • Non-Biodegradable Drug Delivery Technology

Global Implantable Drug Delivery Devices Market - By Application

  • Contraception
  • Cardiovascular
  • Ophthalmology
  • Diabetes
  • Oncology
  • Autoimmune Diseases
  • Others

Global Implantable Drug Delivery Devices Market - By End user

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Global Implantable Drug Delivery Devices Market - By Region

  • North America
  • South America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Table of Contents

1. Global Implantable Drug Delivery Devices Market - Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Implantable Drug Delivery Devices Market - Market Definition and Overview

3. Global Implantable Drug Delivery Devices Market - Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Technology
  • 3.3. Market Snippet by Application
  • 3.4. Market Snippet by End user
  • 3.5. Market Snippet by Region

4. Global Implantable Drug Delivery Devices Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. A novel treatment system for neurological medical emergencies is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of the devices and surgeries are expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Implantable Drug Delivery Devices Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Reimbursement Analysis
  • 5.5. Unmet Needs

6. Global Implantable Drug Delivery Devices Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Implantable Drug Delivery Devices Market - By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Contraceptive Implants*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Spinal Implants
  • 7.4. Infusion Pumps
  • 7.5. Intraocular Stents
  • 7.6. Bio-absorbable Stents
  • 7.7. Drug-Eluting Stents
  • 7.8. Brachytherapy Seeds
  • 7.9. Others

8. Global Implantable Drug Delivery Devices Market - By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology Segment
  • 8.2. Biodegradable Drug Delivery Technology*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Non-Biodegradable Drug Delivery Technology

9. Global Implantable Drug Delivery Devices Market - By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application Segment
  • 9.2. Contraception*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Cardiovascular
  • 9.4. Ophthalmology
  • 9.5. Diabetes
  • 9.6. Oncology
  • 9.7. Autoimmune Diseases
  • 9.8. Others

10. Global Implantable Drug Delivery Devices Market - By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user Segment
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 10.3. Ambulatory Surgery Centers
  • 10.4. Others

11. Global Implantable Drug Delivery Devices Market - By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Global Implantable Drug Delivery Devices Market - Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Global Implantable Drug Delivery Devices Market- Company Profiles

  • 13.1. Abbott Laboratories*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. AbbVie Inc.
  • 13.3. Delpor Inc.
  • 13.4. Medtronic
  • 13.5. Bausch & Lomb
  • 13.6. Cognos Therapeutics, Inc.
  • 13.7. Bayer
  • 13.8. Zimmer Biomet
  • 13.9. Elixir Medical Corporation
  • 13.10. DSM Biomedical

LIST NOT EXHAUSTIVE

14. Global Implantable Drug Delivery Devices Market - DataM

  • 14.1. Appendix
  • 14.2. About Us
  • 14.3. Contact Us